A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma.
Xiao WangSharyn KatzJohn MiuraGiorgos KarakousisLeonid RoshkovanSuzanne WalkerSally McNultyChristine CiunciKeith CengelCorey J LangerMelina E MarmarelisPublished in: PloS one (2022)
When used preferentially, the use of neoadjuvant chemotherapy in DMPM patients was not associated with worse outcomes compared to adjuvant chemotherapy. It was well-tolerated and did not prevent surgical intervention.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- lymph node
- peritoneal dialysis
- squamous cell carcinoma
- cardiac surgery
- rectal cancer
- prognostic factors
- radiation therapy
- low grade
- early stage
- acute kidney injury
- patient reported outcomes